The PrEP DC Act of 2025 aims to enhance access to HIV prevention treatments in the District of Columbia by implementing several key provisions. The bill prohibits health benefit plans and insurers from using prescription information related to HIV as a condition for eligibility or in determining premium rates. Additionally, it prevents insurers from imposing restrictions or delays on the distribution of antiretroviral drugs prescribed for HIV treatment or prevention. Importantly, the legislation also eliminates any cost-sharing requirements, such as deductibles or copayments, for pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP), thereby making these essential treatments more accessible to individuals at risk of HIV infection.

The bill emphasizes the importance of reducing stigma and discrimination associated with accessing HIV prevention treatments, particularly for the LGBTQ community. It mandates that all health plans provide coverage for HIV prevention treatments in accordance with the latest guidelines from the U.S. Centers for Disease Control and Prevention, ensuring that such coverage is not more restrictive than that for other medical conditions. The provisions of the act will apply to all individual and group health benefit plans issued or renewed after a specified date, and the Commissioner of the Department of Insurance and Securities Regulation is authorized to issue necessary regulations for implementation.